Skip to main content

MoneyWorks4Me

Dr Reddy’s Laboratories informs about press release

28 Jan 2019 Evaluate

Dr Reddy’s Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories and its US subsidiary, Promius Pharma, announce FDA approval for TOSYMRA (sumatriptan nasal spray) 10 mg, in the US market.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..